270 related articles for article (PubMed ID: 12552014)
1. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication.
Mothé BR; Weinfurter J; Wang C; Rehrauer W; Wilson N; Allen TM; Allison DB; Watkins DI
J Virol; 2003 Feb; 77(4):2736-40. PubMed ID: 12552014
[TBL] [Abstract][Full Text] [Related]
2.
Martins MA; Tully DC; Pedreño-Lopez N; von Bredow B; Pauthner MG; Shin YC; Yuan M; Lima NS; Bean DJ; Gonzalez-Nieto L; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Bailey VK; Altman JD; Burton DR; Ejima K; Allison DB; Evans DT; Rakasz EG; Parks CL; Bonaldo MC; Capuano S; Lifson JD; Desrosiers RC; Allen TM; Watkins DI
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875239
[TBL] [Abstract][Full Text] [Related]
3. Mamu-B*08-positive macaques control simian immunodeficiency virus replication.
Loffredo JT; Maxwell J; Qi Y; Glidden CE; Borchardt GJ; Soma T; Bean AT; Beal DR; Wilson NA; Rehrauer WM; Lifson JD; Carrington M; Watkins DI
J Virol; 2007 Aug; 81(16):8827-32. PubMed ID: 17537848
[TBL] [Abstract][Full Text] [Related]
4. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication.
Yant LJ; Friedrich TC; Johnson RC; May GE; Maness NJ; Enz AM; Lifson JD; O'Connor DH; Carrington M; Watkins DI
J Virol; 2006 May; 80(10):5074-7. PubMed ID: 16641299
[TBL] [Abstract][Full Text] [Related]
5. Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques.
Valentine LE; Loffredo JT; Bean AT; León EJ; MacNair CE; Beal DR; Piaskowski SM; Klimentidis YC; Lank SM; Wiseman RW; Weinfurter JT; May GE; Rakasz EG; Wilson NA; Friedrich TC; O'Connor DH; Allison DB; Watkins DI
J Virol; 2009 Nov; 83(22):11514-27. PubMed ID: 19726517
[TBL] [Abstract][Full Text] [Related]
6. Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.
Loffredo JT; Bean AT; Beal DR; León EJ; May GE; Piaskowski SM; Furlott JR; Reed J; Musani SK; Rakasz EG; Friedrich TC; Wilson NA; Allison DB; Watkins DI
J Virol; 2008 Feb; 82(4):1723-38. PubMed ID: 18057253
[TBL] [Abstract][Full Text] [Related]
7. Control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes.
Wojcechowskyj JA; Yant LJ; Wiseman RW; O'Connor SL; O'Connor DH
J Virol; 2007 Jan; 81(1):406-10. PubMed ID: 17079280
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques.
Maness NJ; Yant LJ; Chung C; Loffredo JT; Friedrich TC; Piaskowski SM; Furlott J; May GE; Soma T; León EJ; Wilson NA; Piontkivska H; Hughes AL; Sidney J; Sette A; Watkins DI
J Virol; 2008 Jun; 82(11):5245-54. PubMed ID: 18385251
[TBL] [Abstract][Full Text] [Related]
9. MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys.
Mühl T; Krawczak M; Ten Haaft P; Hunsmann G; Sauermann U
J Immunol; 2002 Sep; 169(6):3438-46. PubMed ID: 12218167
[TBL] [Abstract][Full Text] [Related]
10. The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.
Giraldo-Vela JP; Rudersdorf R; Chung C; Qi Y; Wallace LT; Bimber B; Borchardt GJ; Fisk DL; Glidden CE; Loffredo JT; Piaskowski SM; Furlott JR; Morales-Martinez JP; Wilson NA; Rehrauer WM; Lifson JD; Carrington M; Watkins DI
J Virol; 2008 Jan; 82(2):859-70. PubMed ID: 17989178
[TBL] [Abstract][Full Text] [Related]
11. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
[TBL] [Abstract][Full Text] [Related]
12. Two Human Monoclonal HLA-Reactive Antibodies Cross-React with Mamu-B*008, a Rhesus Macaque MHC Allotype Associated with Control of Simian Immunodeficiency Virus Replication.
de Groot NG; Heijmans CMC; Bezstarosti S; Bruijnesteijn J; Haasnoot GW; Mulder A; Claas FHJ; Heidt S; Bontrop RE
J Immunol; 2021 Apr; 206(8):1957-1965. PubMed ID: 33692147
[TBL] [Abstract][Full Text] [Related]
13. High viremia is associated with high levels of in vivo major histocompatibility complex class I Downregulation in rhesus macaques infected with simian immunodeficiency virus SIVmac239.
Friedrich TC; Piaskowski SM; León EJ; Furlott JR; Maness NJ; Weisgrau KL; Mac Nair CE; Weiler AM; Loffredo JT; Reynolds MR; Williams KY; Klimentidis YC; Wilson NA; Allison DB; Rakasz EG
J Virol; 2010 May; 84(10):5443-7. PubMed ID: 20219903
[TBL] [Abstract][Full Text] [Related]
14. SIV-infected Chinese-origin rhesus macaques express specific MHC class I alleles in either elite controllers or normal progressors.
Wambua D; Henderson R; Solomon C; Hunter M; Marx P; Sette A; Mothé BR
J Med Primatol; 2011 Aug; 40(4):244-7. PubMed ID: 21781132
[TBL] [Abstract][Full Text] [Related]
15. Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides.
Schafer JL; Ries M; Guha N; Connole M; Colantonio AD; Wiertz EJ; Wilson NA; Kaur A; Evans DT
PLoS Pathog; 2015 Sep; 11(9):e1005145. PubMed ID: 26333068
[TBL] [Abstract][Full Text] [Related]
16. Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response.
Boyer JD; Kumar S; Robinson T; Parkinson R; Wu L; Lewis M; Weiner DB
J Med Primatol; 2006 Aug; 35(4-5):202-9. PubMed ID: 16872283
[TBL] [Abstract][Full Text] [Related]
17. The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection.
Reed JS; Sidney J; Piaskowski SM; Glidden CE; León EJ; Burwitz BJ; Kolar HL; Eernisse CM; Furlott JR; Maness NJ; Walsh AD; Rudersdorf RA; Bardet W; McMurtrey CP; O'Connor DH; Hildebrand WH; Sette A; Watkins DI; Wilson NA
Immunogenetics; 2011 Dec; 63(12):789-807. PubMed ID: 21732180
[TBL] [Abstract][Full Text] [Related]
18. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.
Evans DT; Bricker JE; Sanford HB; Lang S; Carville A; Richardson BA; Piatak M; Lifson JD; Mansfield KG; Desrosiers RC
J Virol; 2005 Jun; 79(12):7707-20. PubMed ID: 15919923
[TBL] [Abstract][Full Text] [Related]
19. Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers.
Mudd PA; Ericsen AJ; Burwitz BJ; Wilson NA; O'Connor DH; Hughes AL; Watkins DI
J Immunol; 2012 Apr; 188(7):3364-70. PubMed ID: 22387557
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated control.
Beck SE; Queen SE; Viscidi R; Johnson D; Kent SJ; Adams RJ; Tarwater PM; Mankowski JL
J Neurovirol; 2016 Aug; 22(4):498-507. PubMed ID: 26727909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
